History

The Story — RS Technologies Co., Ltd. (3445)

The story since 2018 is one company in two halves: a quietly excellent reclaimed-wafer monopolist (Sanbongi/Tainan) bolted to a capital-hungry, cyclical, geopolitically exposed Chinese prime-wafer adventure (GRITEK/SGRS). Management's narrative has stayed remarkably consistent on what RST does, but the frame has cycled — from "comprehensive wafer manufacturer" (2018–2022), to "asset-value gap with a listed subsidiary" (2023), to a multi-engine conglomerate ("LE System + M&A upside", 2023–2024), and most recently to a "focused investment phase" (2025–2026) that quietly accepts margin compression and slips the China 12-inch ramp. The reclaimed-wafer chassis has delivered every promise made about it; almost every other promise — LE System scale, 12-inch prime ramp, the ¥131 billion Upside Plan — has been walked back without ever being formally retired. Credibility on the core is high; credibility on the adjacencies is fading.

1. The Narrative Arc

Founder/CEO Nagayoshi Ho has been at the helm since the company was established on 10 December 2010. There has been no leadership transition. The current strategic chapter — RST as a "comprehensive wafer manufacturer" rather than a pure reclaimer — began in January 2018 when the Chinese prime-wafer maker GRITEK became a consolidated subsidiary. Every later twist (GRITEK STAR IPO 2022; LE System 2023; RSPDH 2024; holding-company transition disclosed Dec 2024) is a branch off that 2018 trunk.

The chart above frames everything else on this page. FY2018 is when revenue stepped up 2.3× — that is the GRITEK consolidation. FY2022 is when both revenue and margin peaked together — that is the GRITEK IPO year and the post-COVID semiconductor cycle peak. Every period after FY2022 has shown revenue continuing to grow while operating margin contracts. The new 2026–2028 plan formally extends this trajectory: management now guides FY2028 operating margin to 16.5%, down from 22.1% in FY2024 and 26.1% at the FY2022 peak.

2. What Management Emphasized — and Then Stopped Emphasizing

The reclaimed-wafer story stays bolted to every deck (33% global share, world No. 1). What rotates around it is more interesting: each year a "third engine of growth" is named, given a target, and either matured into reality (GRITEK) or quietly demoted (DG Technologies, LE System, the Upside Plan).

Missing required column(s): undefined not found in data set.

What rose: decoupling/regional strategy (1→4 from FY2021 to FY2023 as US-China friction crystallized), ROIC/ROE framework (introduced in FY2024 deck and now central), RSPDH (acquired Dec 2024 and immediately the largest new engine), AI demand for cutting-edge reclaimed wafers (first surfaced in Q4 FY2025 Q&A).

What faded: DG Technologies was the "third engine of growth" with three dedicated pages in the FY2021 and FY2022 decks; by FY2024 it is one bullet in the Semiconductor-related Equipment segment, and in FY2025 management admits it "did not contribute to operating income" and needs a new organizational structure. The "Upside Plan" — explicitly published in Feb 2024 with a ¥131.1 billion FY2026 revenue target including ¥24 B from LE System and ¥43 B from M&A — was not mentioned in the FY2024 or FY2025 mid-term plan slides at all. It was replaced, not corrected.

3. Risk Evolution

The statutory yuho (Japanese securities report) carries roughly the same risk taxonomy every year, but the weight of individual risks moves visibly across the briefing decks, Q&A sessions, and CEO commentary. Three risks have grown materially since 2021; three have receded; one (Middle East logistics) is brand new in Q1 FY2026.

The two risks that have grown most loudly are 8-inch prime wafer ASP erosion (silent until FY2023, by FY2025 it accounts for the entire decline in prime wafer operating income: "the decrease in the unit price of some low-voltage wafers and general-purpose wafers such as IGBTs was noticeable") and capital efficiency below cost of capital. Management introduced the ROIC/ROE framework in February 2025 with confident claims that returns exceed CAPM-based cost of capital; one year later they conceded ROIC fell from 12.7% to 10.8% (vs. 9.0% WACC), accepted that "ROIC and ROE are on a downward trend," and asked investors to wait three years. 12-inch prime wafer ramp risk has also escalated — the equity-method investment loss from SGRS grew from ¥685 M (FY2024) to ¥1.0 B (FY2025), and the production schedule was officially slipped.

What has receded: the semiconductor cycle risk that defined the FY2023 commentary is now framed as past tense, with management arguing the reclaimed wafer business is "less susceptible to the silicon cycle" — a claim the 2023 prime-wafer numbers contradict for the prime side, but that the 40% segment margins in reclaimed largely vindicate.

4. How They Handled Bad News

The two biggest disappointments of the period were (a) the FY2023 prime-wafer cycle (segment sales –17.7%, operating income –37.6%) and (b) the FY2025 8-inch ASP collapse + 12-inch slippage. The handling of each is different and worth contrasting.

FY2023 — clean acknowledgement, framing remained credible. Management acknowledged the miss versus the FY2022 mid-term plan ("operating income decreased 8.6% year-on-year and –9.2% versus plan due to deterioration in the overall semiconductor market"), did not blame one-offs, and continued investing through the cycle. Subsequent reclaimed-wafer outperformance vindicated the framing.

FY2025 — quieter framing of structural margin compression. The FY2025 mid-term plan published Feb 2025 forecast FY2025 operating income of ¥15.1 B; actual came in at ¥14.3 B (–5%). The new mid-term plan published Feb 2026 cuts FY2026 OI to ¥15.4 B (vs. earlier ¥17.7 B path), with operating margin descending 22.1% → 18.6% → 18.3% → 16.7% → 16.5%. When asked directly on the Q4 FY2025 call whether "profitability will continue to decline until 3 years from now due to the large-scale capital investment," management answered: "Our group is currently in the investment phase. Therefore, we have included a plan to temporarily decrease the operating margin." The word temporarily is doing a lot of work in that sentence — the FY2028 endpoint of the new plan still has lower margins than FY2024.

5. Guidance Track Record

The table below filters out routine quarterly guidance and lists only promises that mattered for valuation, capital allocation, or strategic credibility. The pattern is unusually bimodal: every promise about the core wafer business and GRITEK has been delivered or beaten; almost every promise about adjacent businesses and capital efficiency has slipped.

Credibility = 6/10. Management deserves credit for the GRITEK IPO (a multi-year promise delivered on schedule and at a strong valuation), for honest handling of the FY2023 cyclical miss, for pulling Sanbongi Plant 7 forward, and for consistent dividend increases (¥10 → ¥55 per share over six years). The score is held back by a recurring habit: when adjacency targets miss, the next deck publishes lower numbers without acknowledging the prior promise. The Feb 2024 Upside Plan was the most visible example — a ¥131 B target gone in twelve months, never formally retired. The ROIC/ROE thresholds introduced with confidence in Feb 2025 were cut twelve months later. Taken together, the core deserves trust at face value; adjacency targets should be discounted ~30–40% by default.

6. What the Story Is Now

The story today is simpler than it has ever been, even though the consolidated entity is more complex. Reclaimed wafers are a high-quality, hard-to-displace cash engine running at ~37% segment margin and visibly growing. GRITEK 8-inch is mature but cyclical — useful, but already de-rated by the market. Everything else — SGRS 12-inch, LE System, RSPDH camera modules, the holdco restructuring — is option value that may or may not be worth what the consolidated capex line is costing.

De-risked over the period:

• Reclaimed wafer market position (33% global share held for six consecutive years, with Sanbongi/Tainan at full utilization and capacity stepping to 1.19 M/month by 2028)
• GRITEK listing and capital structure (executed cleanly; provided durable cushion of net cash plus listed-equity collateral)
• Decoupling architecture (US 4% of reclaimed shipments; prime sold mainly inside China; little direct tariff exposure)
• Balance sheet (net cash ¥73.3 B at end FY2025; DER 0.32x; investment-phase capex internally funded)

Still stretched:

• 12-inch prime wafer in China (publicly slipped multiple times; equity-method losses growing; "global environment and Japan-China relations" now openly cited as a reason)
• LE System / VRFB economics (FY2025 sales below ¥1 B vs. a former ¥24 B FY2026 plan; mass-production plant in Panzhihua scheduled for 2026 but commercial scale-up is unproven)
• Capital efficiency (ROIC has roughly halved from 19.2% in FY2022 to 10.8% in FY2025 and is now only ~180 bp above WACC; the plan accepts further dilution before recovery)
• RSPDH integration (optical pickup is a sunset business RST acquired for the manufacturing platform; the bull case requires automotive camera modules to scale in a market RST is openly describing as "highly competitive")

What to believe vs. discount:

• Believe at face value: reclaimed wafer capacity ramp, dividend trajectory, GRITEK 8-inch run-rate, and the company's reading of the tariff/decoupling environment.
• Discount by ~30–40%: the time-to-monetization on the 12-inch ramp, the FY2027–2028 revenue acceleration in the new plan (which presupposes RSPDH camera-module success and LE System monetization), and the implicit return-to-mid-20s operating margin after the "investment phase."

RS Technologies is not a turnaround or a transformation story; it is a high-quality core business whose owner has spent six years compounding net cash and capital intensity in roughly equal measure. The next three years will decide whether the diversification was capital efficiency or capital dilution. The evidence reads as inconclusive today — leaning toward dilution if the 12-inch and energy businesses don't show economics by FY2027.